Esperion Therapeutics, Inc. Stock Chart

Esperion Therapeutics, Inc. (LSE) · Health Technology. stock live price and technical analysis view. Follow LSE data on Alerta Chart.

Checking data access...

About Esperion Therapeutics, Inc.

LSE
Market Cap
$665.36M
Shares Out.
201.62M
Sector
Health Technology
Industry
Pharmaceuticals: Major

Esperion Therapeutics, Inc. is a pharmaceutical company, which engages in the development and commercialization of oral therapies for elevated low-density lipoprotein cholesterol. The firm offers NEXLETOL (bempedoic acid) tablets, and NEXLIZET (bempedoic acid and ezetimibe) tablets. The company was founded by Roger S. Newton, Hans Ageland, Jan O. Johansson, Anders Paul Wiklund, Michael E. Pape, David I. Scheer and Charles L. Bisgaier in May 1998 and is headquartered in Ann Arbor, MI.

www.esperion.com

Related Markets

Market Hub:Stocks Hub

Need more analysis tools?

With Alerta Chart Pro Terminal, you can follow 4 charts at the same time, see depth (order book) data and set 25 active alerts.

Start for Free
0IIM.GB (0IIM.GB) Stock Live Chart & Technical Analysis | Alerta Chart | Alerta Chart